Sponsored Publications Archives - Page 19 of 19 - European Biotechnology Magazine

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Phone

This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Name

This field is for validation purposes and should be left unchanged.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

14 Must-Haves to Boost the Efficiency of Your Data Room

Sponsored Publications

Stop wasting time with data room software that doesn’t really improve your workflow.

17 October 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/Drooms_Whitepaper.png 360 640 Maren Kühr /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Maren Kühr2016-10-17 16:12:172016-10-17 16:12:1714 Must-Haves to Boost the Efficiency of Your Data Room

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Sponsored Publications

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

29 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitePaper_Jackson_Labs__May16_.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-29 14:43:002016-09-29 14:43:00Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Sponsored Publications

How Content Access and Manual Process Hinder Mining Efforts

27 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitepaperRightsEBSIN.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-27 14:45:132016-09-27 14:45:13TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Sponsored Publications

14 June 2016

/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png 0 0 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-06-14 18:09:092016-06-14 18:09:09Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 19 of 19«‹17 1819

LATEST NEWS

Cytovation ASA

Cytovation ASA bags additional US$6m to drive Phase...

Traderfox

KKR makes US$1.22bn tender for Swedish Biotage AB

adobe stock - JHVEPhoto

Boehringer Ingelheim inks deal with Tessallate Bio

MAGAZINE

1 / 4

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

2 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

3 / 4

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

4 / 4

The Three R (Replacement, Reduction and Refinement) principles developed over 60 years ago provide a framework for more humane lab animal testing and, more importantly, less of it. A range of in-vitro … more ➔

❮❯